Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Performance of the SpineVision Hexanium ACIF in the Treatment of Cervical Spine Degenerative Disc Disease in Skeletally Mature Patients - HEXANIUM ACIF Study

NCT06155409 is registered in ClinicalTrials.gov with SPINEVISION SAS as lead sponsor.

NCT NCT06155409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06155409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Performance of the SpineVision Hexanium ACIF in the Treatment of Cervical Spine Degenerative Disc Disease in Skeletally Mature Patients - HEXANIUM ACIF Study
Lead sponsor
SPINEVISION SAS
Phase
Observational
Overall status
Active, not recruiting
Start date
July 6, 2021
Completion date
July 31, 2027
Enrollment
148 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

intervertebral disc degeneration